Literature DB >> 20560766

Increased regulatory T cell counts in HIV-infected nonresponders to hepatitis B virus vaccine.

María del Mar del Pozo Balado1, Manuel Leal, Gema Méndez Lagares, Rosario C Mata, Luis F López-Cortés, Pompeyo Viciana, Yolanda M Pacheco.   

Abstract

Hepatitis B virus (HBV) coinfection is a main cause of liver-related mortality in human immunodeficiency virus (HIV)-infected subjects. Unfortunately, HIV-infected subjects show a low rate of response to standard HBV vaccination (23%-56%), in contrast to rates >90% found in the general population, and the underlying causes (particularly cellular and molecular causes) are still unknown. We hypothesized that an increased frequency of regulatory T (T(reg)) cells could be involved in the low rate of seroconversion in HIV-infected subjects. Forty HIV-infected subjects were enrolled in the Assistance Vaccination Program against HBV of the Infectious Diseases Service from the Virgen del Rocío University Hospital, Seville, Spain. Freshly isolated peripheral blood mononuclear cells from baseline were immunophenotyped for T(reg) cells, CD4, and CD8 T cells in both naive and memory subpopulations and activation degree, as well as recent thymic emigrants. Baseline T(reg) cell frequency was found independently associated with the final nonresponse to HBV vaccine in HIV-infected subjects. Furthermore, a negative correlation between baseline frequency of T(reg) cells and antibody titers in the final response was found. These findings suggest an active role played by T(reg) cells on the immunization antigen-specific T and/or B cell responses with the final consequence of a B cell anti-HBs lower production.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20560766     DOI: 10.1086/653707

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

Review 1.  Hepatitis B Vaccination and Waning Hepatitis B Immunity in Persons Living with HIV.

Authors:  Priya D Farooq; Kenneth E Sherman
Journal:  Curr HIV/AIDS Rep       Date:  2019-10       Impact factor: 5.071

2.  Association between a Suppressive Combined Antiretroviral Therapy Containing Maraviroc and the Hepatitis B Virus Vaccine Response.

Authors:  Inés Herrero-Fernández; Yolanda M Pacheco; Ezequiel Ruiz-Mateos; Manuel Leal; Miguel Genebat; María Del Mar Rodriguez-Méndez; María Del Carmen Lozano; María José Polaino; Isaac Rosado-Sánchez; Laura Tarancón-Diez; María Ángeles Muñoz-Fernández
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

3.  The altered PD-1/PD-L1 pathway delivers the 'one-two punch' effects to promote the Treg/Th17 imbalance in pre-eclampsia.

Authors:  Yonghong Zhang; Zhaozhao Liu; Mei Tian; Xiaohui Hu; Liling Wang; Jinlu Ji; Aihua Liao
Journal:  Cell Mol Immunol       Date:  2017-09-11       Impact factor: 11.530

Review 4.  Unsolved problems and future perspectives of hepatitis B virus vaccination.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

5.  Telomere and ATM Dynamics in CD4 T-Cell Depletion in Active and Virus-Suppressed HIV Infections.

Authors:  Sushant Khanal; Qiyuan Tang; Dechao Cao; Juan Zhao; Lam Nhat Nguyen; Oluwayomi Samson Oyedeji; Xindi Dang; Lam Ngoc Thao Nguyen; Madison Schank; Bal Krishna Chand Thakuri; Chinyere Ogbu; Zheng D Morrison; Xiao Y Wu; Zheng Zhang; Qing He; Mohamed El Gazzar; Zhengke Li; Shunbin Ning; Ling Wang; Jonathan P Moorman; Zhi Q Yao
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

Review 6.  Hepatitis B vaccine by intradermal route in non responder patients: an update.

Authors:  Martina Filippelli; Elena Lionetti; Alessia Gennaro; Angela Lanzafame; Teresa Arrigo; Carmelo Salpietro; Mario La Rosa; Salvatore Leonardi
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

Review 7.  Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1.

Authors:  Jennifer A Whitaker; Nadine G Rouphael; Srilatha Edupuganti; Lilin Lai; Mark J Mulligan
Journal:  Lancet Infect Dis       Date:  2012-12       Impact factor: 25.071

8.  Persistence of Protective Hepatitis B Surface Antibody Titers after Successful Double-Dose Hepatitis B Virus Rescue Vaccination in HIV-Infected Patients.

Authors:  Jong Hun Kim; George Psevdos; Vanessa Groce; Victoria Sharp
Journal:  Gut Liver       Date:  2012-01-12       Impact factor: 4.519

9.  Hepatitis B vaccine antibody response and the risk of clinical AIDS or death.

Authors:  Michael L Landrum; Katherine Huppler Hullsiek; Robert J O'Connell; Helen M Chun; Anuradha Ganesan; Jason F Okulicz; Tahaniyat Lalani; Amy C Weintrob; Nancy F Crum-Cianflone; Brian K Agan
Journal:  PLoS One       Date:  2012-03-22       Impact factor: 3.240

10.  Lower frequency of T stem cell memory (TSCM) cells in hepatitis B vaccine nonresponders.

Authors:  Mahsa Eshkevar Vakili; Zahra Faghih; Jamal Sarvari; Mehrnoosh Doroudchi; Seyed Nezamedin Hosseini; Dieter Kabelitz; Kurosh Kalantar
Journal:  Immunol Res       Date:  2022-04-20       Impact factor: 4.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.